ASX - By Stock
|
AN1 |
Re:
Ann: Company Update
|
|
EML333
|
149 |
38K |
1 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
149
|
38K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Company Update
|
|
EML333
|
149 |
38K |
0 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
149
|
38K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Company Update
|
|
EML333
|
149 |
38K |
2 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
149
|
38K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
HODL
|
|
EML333
|
11 |
4.6K |
2 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
11
|
4.6K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
EML333
|
23K |
13M |
0 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
HODL
|
|
EML333
|
11 |
4.6K |
2 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
11
|
4.6K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Company Update
|
|
EML333
|
149 |
38K |
0 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
149
|
38K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Company Update
|
|
EML333
|
149 |
38K |
2 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
149
|
38K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
15/05/20 |
15/05/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
EML333
|
162 |
48K |
1 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
162
|
48K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
EML333
|
162 |
48K |
1 |
13/05/20 |
13/05/20 |
ASX - By Stock
|
162
|
48K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
EML333
|
162 |
48K |
0 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
162
|
48K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
EML333
|
162 |
48K |
1 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
162
|
48K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Suspension from Official Quotation
|
|
EML333
|
162 |
48K |
1 |
11/05/20 |
11/05/20 |
ASX - By Stock
|
162
|
48K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
EML333
|
23K |
13M |
12 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
23K
|
13M
|
12
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
1 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
1 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
1 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
EML333
|
23K |
13M |
3 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
23K
|
13M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
|
|
EML333
|
847 |
335K |
7 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
847
|
335K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
EML333
|
145 |
33K |
2 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
145
|
33K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
EML333
|
145 |
33K |
0 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
145
|
33K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
EML333
|
145 |
33K |
7 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
145
|
33K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
EML333
|
145 |
33K |
1 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
145
|
33K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
EML333
|
145 |
33K |
2 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
145
|
33K
|
2
|
|
ASX - By Stock
|
APT |
Re:
What the depression in Australia would do to apt
|
|
EML333
|
216 |
61K |
3 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
216
|
61K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
EML333
|
145 |
33K |
5 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
145
|
33K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Independent Test Results For The Wondfo SARS-CoV-2 Test
|
|
EML333
|
145 |
33K |
6 |
22/04/20 |
22/04/20 |
ASX - By Stock
|
145
|
33K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
EML333
|
394 |
122K |
1 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
394
|
122K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
EML333
|
394 |
122K |
2 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
394
|
122K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
EML333
|
394 |
122K |
0 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
394
|
122K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
EML333
|
394 |
122K |
0 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
394
|
122K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
EML333
|
394 |
122K |
0 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
394
|
122K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
EML333
|
394 |
122K |
0 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
394
|
122K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
EML333
|
394 |
122K |
1 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
394
|
122K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
EML333
|
394 |
122K |
0 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
394
|
122K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
|
|
EML333
|
394 |
122K |
0 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
394
|
122K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
13/04/20 |
13/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
13/04/20 |
13/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
13/04/20 |
13/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
1 |
11/04/20 |
11/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
4 |
11/04/20 |
11/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
5 |
11/04/20 |
11/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
10 |
11/04/20 |
11/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
10
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
1 |
10/04/20 |
10/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
|
|
EML333
|
1.2K |
409K |
0 |
10/04/20 |
10/04/20 |
ASX - By Stock
|
1.2K
|
409K
|
0
|
|